About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Open Label Extension of LipoLat-CS202

NCT02599688·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Peregrine Ophthalmic

Age

18–99

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Successful completion of 3 months of participation in Study LipoLat-CS202.
2. Treatment with POLAT-001 in Study LipoLat-CS202.
3. Able and willing to give signed informed consent and follow study instructions.

You may not be if

Excluded from the study will be individuals with the following characteristics:

The record

StatusCompleted

PhaseNo phase

Taking part18

StartedNov 2015

UpdatedDec 14, 2020

Conditions

Where1

Professional Research Network
Goose Creek, South Carolina, United States

Clareo Health | Open Label Extension of LipoLat-CS202